Affiliation:
1. Department of Ophthalmology, University Medical Center, Johannes Gutenberg University Mainz, Langenbeckstrasse 1, 55131 Mainz, Germany
Abstract
Retinopathy of prematurity (ROP) is a proliferative vascular ailment affecting the retina. It is the main risk factor for visual impairment and blindness in infants and young children worldwide. If left undiagnosed and untreated, it can progress to retinal detachment and severe visual impairment. Geographical variations in ROP epidemiology have emerged over recent decades, attributable to differing levels of care provided to preterm infants across countries and regions. Our understanding of the causes of ROP, screening, diagnosis, treatment, and associated risk factors continues to advance. This review article aims to present the pathophysiological mechanisms of ROP, including its treatment. Specifically, it delves into the latest cutting-edge treatment approaches targeting hypoxia and redox signaling pathways for this condition.
Subject
Cell Biology,Clinical Biochemistry,Molecular Biology,Biochemistry,Physiology
Reference221 articles.
1. Vascular imaging findings in retinopathy of prematurity;Rowe;Acta Ophthalmol.,2023
2. Prognostic factors in the natural course of retinopathy of prematurity;Schaffer;Ophthalmology,1993
3. Retinopathy of prematurity: A risk factor analysis with univariate and multivariate statistics;Bossi;Helv. Paediatr. Acta,1984
4. Evaluation of oxygen supplementation status as a risk factor associated with the development of severe retinopathy of prematurity;Enomoto;Ophthalmologica,2015
5. Retinopathy of prematurity: A review of risk factors and their clinical significance;Kim;Surv. Ophthalmol.,2018